Parallel labeling experiments validate Clostridium acetobutylicum metabolic network model for 13C metabolic flux analysis

In this work, we provide new insights into the metabolism of Clostridium acerobutylicum ATCC 824 obtained using a systematic approach for quantifying fluxes based on parallel labeling experiments and C-13-metabolic flux analysis (C-13-MFA). Here, cells were grown in parallel cultures with [1-C-13]glucose and [U-C-13]glucose as tracers and C-13-MFA was used to quantify intracellular metabolic fluxes. Several metabolic network models were compared: an initial model based on current knowledge, and extended network models that included additional reactions that improved the fits of experimental data. While the initial network model did not produce a statistically acceptable fit of C-13-labeling data, an extended network model with five additional reactions was able to fit all data with 292 redundant measurements. The model was subsequently trimmed to produce a minimal network model of C acetobutylicum for C-13-MFA, which could still reproduce all of the experimental data The flux results provided valuable new insights into the metabolism of C. acetobutylicurn. First, we found that TCA cycle was effectively incomplete, as there was no measurable flux between alpha-ketoglutarate and succinyl-CoA, succinate and fumarate, and malate and oxaloacetate. Second, an active pathway was identified from pyruvate to fumarate via aspartate. Third, we found that isoleucine was produced exclusively through the citramalate synthase pathway in C acetobtaylicurn and that CAC3174 was likely responsible for citramalate synthase activity. These model predictions were confirmed in several follow-up tracer experiments. The validated metabolic network model established in this study can be used in future investigations for unbiased C-13-flux measurements in C. acetobutylicum. (C) 2014 International Metabolic Engineering Society. Published by Elsevier Inc. All rights reserved,